BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35398599)

  • 21. Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency.
    Józsi M; Licht C; Strobel S; Zipfel SL; Richter H; Heinen S; Zipfel PF; Skerka C
    Blood; 2008 Feb; 111(3):1512-4. PubMed ID: 18006700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical haemolytic uraemic syndrome associated with a hybrid complement gene.
    Venables JP; Strain L; Routledge D; Bourn D; Powell HM; Warwicker P; Diaz-Torres ML; Sampson A; Mead P; Webb M; Pirson Y; Jackson MS; Hughes A; Wood KM; Goodship JA; Goodship TH
    PLoS Med; 2006 Oct; 3(10):e431. PubMed ID: 17076561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable four-yr outcome after renal transplantation in a patient with complement factor H antibody and CFHR1/CFHR3 gene mutation-associated HUS.
    Grenda R; Jarmużek W; Rubik J; Prokurat S; Miklaszewska M; Drozdz D; Zachwieja K; Ardissino G; Hofer J
    Pediatr Transplant; 2015 Sep; 19(6):E130-4. PubMed ID: 26087050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele
    Pouw RB; Gómez Delgado I; López Lera A; Rodríguez de Córdoba S; Wouters D; Kuijpers TW; Sánchez-Corral P
    Front Immunol; 2018; 9():848. PubMed ID: 29740447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications.
    Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M;
    Ann Med; 2006; 38(8):592-604. PubMed ID: 17438673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement factor H related proteins (CFHRs).
    Skerka C; Chen Q; Fremeaux-Bacchi V; Roumenina LT
    Mol Immunol; 2013 Dec; 56(3):170-80. PubMed ID: 23830046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Copy number variation in the complement factor H-related genes and age-related macular degeneration.
    Kubista KE; Tosakulwong N; Wu Y; Ryu E; Roeder JL; Hecker LA; Baratz KH; Brown WL; Edwards AO
    Mol Vis; 2011; 17():2080-92. PubMed ID: 21850184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel deletion in the RCA gene cluster causes atypical hemolytic uremic syndrome.
    Maga TK; Meyer NC; Belsha C; Nishimura CJ; Zhang Y; Smith RJ
    Nephrol Dial Transplant; 2011 Feb; 26(2):739-41. PubMed ID: 20974643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration.
    Ansari M; McKeigue PM; Skerka C; Hayward C; Rudan I; Vitart V; Polasek O; Armbrecht AM; Yates JR; Vatavuk Z; Bencic G; Kolcic I; Oostra BA; Van Duijn CM; Campbell S; Stanton CM; Huffman J; Shu X; Khan JC; Shahid H; Harding SP; Bishop PN; Deary IJ; Moore AT; Dhillon B; Rudan P; Zipfel PF; Sim RB; Hastie ND; Campbell H; Wright AF
    Hum Mol Genet; 2013 Dec; 22(23):4857-69. PubMed ID: 23873044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD).
    Fritsche LG; Lauer N; Hartmann A; Stippa S; Keilhauer CN; Oppermann M; Pandey MK; Köhl J; Zipfel PF; Weber BH; Skerka C
    Hum Mol Genet; 2010 Dec; 19(23):4694-704. PubMed ID: 20843825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical haemolytic-uraemic syndrome due to heterozygous mutations of CFH/CFHR1-3 and complement factor H 479.
    Chaudhary P; Hepgur M; Sarkissian S; Smith RJ; Weitz IC
    Blood Transfus; 2014 Jan; 12(1):111-3. PubMed ID: 24333077
    [No Abstract]   [Full Text] [Related]  

  • 32. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.
    Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ
    J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factor H autoantibodies and deletion of Complement Factor H-Related protein-1 in rheumatic diseases in comparison to atypical hemolytic uremic syndrome.
    Foltyn Zadura A; Zipfel PF; Bokarewa MI; Sturfelt G; Jönsen A; Nilsson SC; Hillarp A; Saxne T; Trouw LA; Blom AM
    Arthritis Res Ther; 2012 Aug; 14(4):R185. PubMed ID: 22894814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complement Genetic Variants and FH Desialylation in
    Gómez Delgado I; Corvillo F; Nozal P; Arjona E; Madrid Á; Melgosa M; Bravo J; Szilágyi Á; Csuka D; Veszeli N; Prohászka Z; Sánchez-Corral P
    Front Immunol; 2021; 12():641656. PubMed ID: 33777036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A haplotype in CFH family genes confers high risk of rare glomerular nephropathies.
    Ding Y; Zhao W; Zhang T; Qiang H; Lu J; Su X; Wen S; Xu F; Zhang M; Zhang H; Zeng C; Liu Z; Chen H
    Sci Rep; 2017 Jul; 7(1):6004. PubMed ID: 28729648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.
    Krid S; Roumenina LT; Beury D; Charbit M; Boyer O; Frémeaux-Bacchi V; Niaudet P
    Am J Transplant; 2012 Jul; 12(7):1938-44. PubMed ID: 22494769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement factor H related proteins in immune diseases.
    Skerka C; Zipfel PF
    Vaccine; 2008 Dec; 26 Suppl 8():I9-14. PubMed ID: 19388158
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.
    Togarsimalemath SK; Sethi SK; Duggal R; Le Quintrec M; Jha P; Daniel R; Gonnet F; Bansal S; Roumenina LT; Fremeaux-Bacchi V; Kher V; Dragon-Durey MA
    Kidney Int; 2017 Oct; 92(4):876-887. PubMed ID: 28729035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A De Novo Deletion in the Regulators of Complement Activation Cluster Producing a Hybrid Complement Factor H/Complement Factor H-Related 3 Gene in Atypical Hemolytic Uremic Syndrome.
    Challis RC; Araujo GS; Wong EK; Anderson HE; Awan A; Dorman AM; Waldron M; Wilson V; Brocklebank V; Strain L; Morgan BP; Harris CL; Marchbank KJ; Goodship TH; Kavanagh D
    J Am Soc Nephrol; 2016 Jun; 27(6):1617-24. PubMed ID: 26490391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications.
    Hageman GS; Hancox LS; Taiber AJ; Gehrs KM; Anderson DH; Johnson LV; Radeke MJ; Kavanagh D; Richards A; Atkinson J; Meri S; Bergeron J; Zernant J; Merriam J; Gold B; Allikmets R; Dean M
    Ann Med; 2006; 38(8):592-604. PubMed ID: 28950782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.